Abstract:10564 Background: Colorectal cancer (CRC) represents the 4th common cancer in China with more than 170,000 new cases annually. In Shanghai, CRC increased rapidly during the latest decade (second most common cancer), and its early detection remains a major public health challenge. Fecal occult blood testing and colonoscopy aim to identify CRC patients from symptomatic or asymptomatic people, but both require heavy logistics. A simpler blood-based test would represent an interesting alternative. DNA-microarrays and PAXgene are used to study the gene expression repertoire in peripheral blood samples, suitable for new biomarker discovery. Methods: 119 CRC patients without previous radiotherapy or chemotherapy and 101 colonoscopy-negative controls without polyps or CRC were enrolled in our study. RNA extracted from peripheral blood samples collected in PAXgene tubes, were analysed after NuGEN WT-Ovation RNA amplification, using Affymetrix GeneChip HG-U133 Plus 2.0 Array. Molecular signature analysis was performed based on 5-fold cross validation process. In each iteration, 95 CRC and 80 control samples were randomly assigned to training set for gene selection and classification model training. The retained 24 CRC and 21 control samples were used as test set to assess the classification model performance. The process was repeated for 1000 iterations. Eventually, accuracy, sensitivity and specificity were used to assess the overall performance. Results: One thousand of 100-gene based SVM classifiers were studied. The performance observed was overall accuracy 0.93 (95%CI: 0.928-0.932), sensitivity 0.93 (95%CI: 0.926-0.934) and specificity 0.92 (95%CI: 0.916-0.924). The majority of selected genes represent cell death, cell adhesion, immune system development and signal transduction information, indicating the molecular changes occurring during colorectal cancer progression. Conclusions: Our results demonstrate the feasibility of gene expression profiling in peripheral whole blood for biomarker discovery for early detection of colorectal cancer. Validation of these findings in larger independent series are ongoing, strongly motivated by the performance observed at this stage. Author Disclosure Employment or Leadership Position Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration bioMerieux

Establishing High-Accuracy Biomarkers For Colorectal Cancer By Comparing Fecal Microbiomes In Patients With Healthy Families

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

Elucidating the Gut Microbiome of Colorectal Cancer: 40 Fecal Bacteria as Non-invasive Biomarkers

Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies

Identification of Microbial Markers Across Populations in Early Detection of Colorectal Cancer

Taxonomic and functional profiling of fecal metagenomes for the early detection of colorectal cancer

Circulating Bacterial DNA As a Tool Towards Noninvasive Biomarkers for Colorectal Adenocarcinoma and Adenoma.

Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer

Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites

A New Biomarker of Fecal Bacteria for Non-Invasive Diagnosis of Colorectal Cancer

Using Whole-Genome Sequencing (WGS) to Plot Colorectal Cancer-Related Gut Microbiota in a Population with Varied Geography

Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer

Fecal Bacteria as Non-Invasive Biomarkers for Colorectal Adenocarcinoma

A multiple-dimension model for microbiota of patients with colorectal cancer from normal participants and other intestinal disorders

Metagenomic Analyses Expand Bacterial and Functional Profiling Biomarkers for Colorectal Cancer in a Hainan Cohort, China

The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma

Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers

Use of Peripheral Blood Mrna Signatures to Distinguish Colorectal Cancer Patients from Colonoscopy-Negative Patients

Colorectal cancer-specific microbiome in peripheral circulation and cancer tissues

Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer